These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4379815)

  • 21. Response of isolated guinea-pig atria to various ganglion-stimulating agents.
    Bhagat B
    J Pharmacol Exp Ther; 1966 Nov; 154(2):264-70. PubMed ID: 4380742
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of bethanidine on response to ergotamine and noradrenaline.
    Follenfant M; Green AF
    Br J Pharmacol; 1970 May; 39(1):225P-226P. PubMed ID: 4392964
    [No Abstract]   [Full Text] [Related]  

  • 23. Potentiation of actions of catecholamines by a derivative of hemicholinium.
    Wong S; Long JP
    J Pharmacol Exp Ther; 1967 Jun; 156(3):469-82. PubMed ID: 4381801
    [No Abstract]   [Full Text] [Related]  

  • 24. Optical isomers of beta-hydroxyphenethylguanidine: effects on heart noradrenaline and on sympathetic blockade.
    Fielden R; Green AL
    Br J Pharmacol Chemother; 1968 Feb; 32(2):350-9. PubMed ID: 5646312
    [No Abstract]   [Full Text] [Related]  

  • 25. Mechanism of supersensitivity to catecholamines following chloroquine.
    Pandya KH; Jindal MN; Kelkar VV
    Arzneimittelforschung; 1968 Jul; 18(7):786-90. PubMed ID: 5755820
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of myocardial catecholamines on the cardiac action of ouabain.
    Swamy VC; Hamlin RL; Wolf HH
    J Pharm Sci; 1965 Oct; 54(10):1505-7. PubMed ID: 5883226
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of neurolytic substances on the activity of sulfur-containing radioprotective preparations].
    Strelkov RB
    Radiobiologiia; 1967; 7(6):939-40. PubMed ID: 4391452
    [No Abstract]   [Full Text] [Related]  

  • 28. Demonstration by the histochemical fluorescence method of the prolonged disappearance of catecholamines from the denervated nictitating membrane of the cat.
    Weiner N; Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1967 Aug; 157(2):284-9. PubMed ID: 6039820
    [No Abstract]   [Full Text] [Related]  

  • 29. [The protective effect of 2-mercaptoethylguanidine 1-2H2SO4 against x-ray injury--determination based on dose-testicular weight curve of the mouse].
    Okamura S; Nakamura H; Koga M; Yasukochi A; Takeshita T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1968 Feb; 27(11):1501-5. PubMed ID: 5244666
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cardiovascular effects of high doses of thiamine in dogs and cats. Variations in terms of different factors and attempt of explanation].
    Boissier JR; Viars P; Giudicelli JF; Mouille P
    Anesth Analg (Paris); 1968; 25(6):625-36. PubMed ID: 4389492
    [No Abstract]   [Full Text] [Related]  

  • 31. Studies on mechanisms controlling the secretion of neurotransmitters in the rabbit heart.
    Wennmalm A
    Acta Physiol Scand Suppl; 1971; 365():1-36. PubMed ID: 4398036
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of drugs on uptake and release of catecholamines in the isolated left atrium of the guinea pig.
    Cervoni P; Kirpekar SM; Schwab A
    J Pharmacol Exp Ther; 1966 Feb; 151(2):196-206. PubMed ID: 5932598
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypotensive activity of beta-heptamethylenimino-ethylaminoguanidine sulfate.
    Botton I; Kinnard WJ; Buckley JP
    J Pharmacol Exp Ther; 1966 May; 152(2):243-50. PubMed ID: 5944368
    [No Abstract]   [Full Text] [Related]  

  • 34. Histochemical and fine structural aspects of the onset of denervation supersensitivity in the nictitating membrane of the spinal cat.
    Van Orden LS; Bensch KG; Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1967 Aug; 157(2):274-83. PubMed ID: 6039819
    [No Abstract]   [Full Text] [Related]  

  • 35. New norepinephrine-depleting agents. Beta-hydroxyphenethylguanidine and related compounds.
    Green AL; Fielden R; Bartlett DC; Cozens MJ; Eden RJ; Hills DW
    J Med Chem; 1967 Nov; 10(6):1006-8. PubMed ID: 6056024
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of stereochemistry and lipophilicity on biological activity of some ganglionic blocking agents.
    Wiley RA; Faraj BA; Jantz A; Hava MM
    J Med Chem; 1972 Apr; 15(4):374-8. PubMed ID: 4111939
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological properties of dehydroascorbic acid and ascorbic acid. Effects on the central and peripheral nervous systems in experimental animals.
    Sjöstrand SE
    Acta Physiol Scand Suppl; 1970; 356():1-79. PubMed ID: 5279048
    [No Abstract]   [Full Text] [Related]  

  • 38. Facilitation of ganglionic transmission by some adrenergic neurone blocking drugs.
    Farmer JB; Rand MJ; Wilson J
    Int J Neuropharmacol; 1966 May; 5(3):241-6. PubMed ID: 4380550
    [No Abstract]   [Full Text] [Related]  

  • 39. [The mechanism of action of sympatholytics of the guanethidine series].
    Vinogradov VM; Spivakova RP
    Farmakol Toksikol; 1973; 36(3):273-6. PubMed ID: 4788482
    [No Abstract]   [Full Text] [Related]  

  • 40. THE SYMPATHOMIMETIC EFFECTS OF 2-PYRIDINE ALDOXIME METHYLCHLORIDE (2-PAM CL).
    ZARRO VJ; DIPALMA JR
    J Pharmacol Exp Ther; 1965 Feb; 147():153-60. PubMed ID: 14259492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.